Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: wishful thinking ...

in new hands, in the right hands, it would be a more dangerous patent to infringe.

Also, putting aside the realistic price it would take to purchase the MMP Patents for the moment ... each of the impacted parties, be they owners or creditors, can argue advantages and benefits of accelerating their exit strategy.

The more sticky or unraveled the BK remains or becomes, the greater the odds of a 3rd party offerer stepping forward becomes.

I don't know, we'll see if it happens.

Share
New Message
Please login to post a reply